Vertex Pharmaceuticals’s (0QZU) Moving Averages Convergence Divergence (MACD) indicator is 8.47, suggesting Vertex Pharmaceuticals is a Sell.
Vertex Pharmaceuticals’s (0QZU) 20-Day exponential moving average is 536.36, while Vertex Pharmaceuticals’s (0QZU) share price is $539.54, making it a Buy.
Vertex Pharmaceuticals’s (0QZU) 50-Day exponential moving average is 525.49, while Vertex Pharmaceuticals’s (0QZU) share price is $539.54, making it a Buy.
Vertex Pharmaceuticals’s (0QZU) 10-Day exponential moving average is 543.27, while Vertex Pharmaceuticals’s (0QZU) share price is $539.54, making it a Buy.
Vertex Pharmaceuticals’s (0QZU) 100-Day exponential moving average is 511.91, while Vertex Pharmaceuticals’s (0QZU) share price is $539.54, making it a Buy.
Vertex Pharmaceuticals’s (0QZU) stock price is $539.54 and Vertex Pharmaceuticals’s (0QZU) 50-day simple moving average is 522.91, creating a Buy signal.
Vertex Pharmaceuticals’s (0QZU) stock price is $539.54 and Vertex Pharmaceuticals’s (0QZU) 100-day simple moving average is 515.06, creating a Buy signal.
Vertex Pharmaceuticals’s (0QZU) stock price is $539.54 and Vertex Pharmaceuticals’s (0QZU) 200-day simple moving average is 484.14, creating a Buy signal.